apo-go pfs solution for infusion 5mg/ml
britannia pharmaceuticals limited - apomorphine hydrochloride - solution for infusion - apomorphine hydrochloride 5 mg/ml - anti-parkinson drugs
apo-go pen solution for injection 10mg/ml
britannia pharmaceuticals limited - apomorphine hydrochloride - solution for injection - apomorphine hydrochloride 10 mg/ml - anti-parkinson drugs
apomorphine wockhardt apomorphine hydrochloride hemihydrate 10 mg/ml solution for injection or infusion ampoule
wockhardt bio pty ltd - apomorphine hydrochloride hemihydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium hydroxide; hydrochloric acid; water for injections - apomorphine wockhardt solution for injection or infusion is indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.
apo-go inj.sol 10mg/ml
itf hellas ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΗ ΕΤΑΙΡΕΙΑ Δ.Τ. itf hellas s.a. Αρεως 103 & Αγίας Τριάδος 36,, 175 62 17562, Π. Φάληρο 210.9373332 - apomorphine hydrochloride - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 10mg/ml - apomorphine hydrochloride 10mg - apomorphine
apo-go
abic marketing ltd, israel - apomorphine hydrochloride - solution for injection / infusion - apomorphine hydrochloride 10 mg/ml - apomorphine - apomorphine - treatment of motor fluctuations (“on-off” phenomena) in patients with parkinson's disease which are not sufficiently controlled by oral anti-parkinson medication.
apo go pen 10 mgml
teva israel ltd - apomorphine hydrochloride - solution for injection - apomorphine hydrochloride 10 mg/ml - apomorphine - apomorphine - treatment of motor fluctuations (“on-off” phenomena) in patients with parkinson's disease which are not sufficiently controlled by oral anti-parkinson medication.
apomine apomorphine hydrochloride hemihydrate 100 mg/20 ml solution for infusion vial
interpharma pty ltd - apomorphine hydrochloride hemihydrate, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; hydrochloric acid; water for injections - indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.
apo-go-amp 10 mg/ml sol. inj./perf. s.c. amp.
eg sa-nv - chlorhydrate d'apomorphine 10 mg/ml - solution injectable/pour perfusion - 10 mg/ml - chlorhydrate d'apomorphine 10 mg/ml - apomorphine
apo-go-amp 10 mg/ml sol. inj./perf. s.c. amp.
eg sa-nv - chlorhydrate d'apomorphine 10 mg/ml - solution injectable/pour perfusion - 10 mg/ml - chlorhydrate d'apomorphine 10 mg/ml - apomorphine
apo-go-pen 10 mg/ml sol. inj. s.c. cart.
eg sa-nv - chlorhydrate d'apomorphine 30 mg/3 ml - solution injectable - 10 mg/ml - chlorhydrate d'apomorphine 10 mg/ml - apomorphine